Angiogenesis Inhibitors And Stimulators Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Posted by : ptk
on 04:31
Angiogenesis is a physiological process that is associated
withthe formation of new blood vessel from existing blood vessels.
Angiogenesis process is commonly categorized into two types namely sprouting
angiogenesis and intussusceptive angiogenesis. Sprouting angiogenesis is a
fundamental mechanism of vessel growth in which formation of new blood vessel
is regulated by sequential steps. Intussusceptive angiogenesis (also called as
splitting angiogenesis) is referred where new blood vessel is created by internal
division of an existing blood vessel.
Browse Full Report With TOC:
In contrast to sprouting angiogenesis, intussusceptive do not
need local endothelial cell proliferation. Angiogenesis is mainly associated
with the diverse set of conditions such as age related macular degradation,
rheumatoid arthritis, cancer and psoriasis.The main focus of angiogenesis
therapy is to shrink the existing tumor by aninhibitor or to meet the demand
of under perfused region through generating new vessels by angiogenesis
stimulator. Avastin (bevacizumab), Gleevec, Tarceva and Iressa are some of the
largest selling angiogenesis inhibitor drugs worldwide.
Research and development activitiesfor the development of novel
angiogenesis drugs for cancer treatment is the highest.Thus, increasing number
of cancer cases will drive the growth of this market during the forecast
period. According to World Health Organization, approximately 8.2 million
deaths are reported in the year of 2012 due to cancer. Also it is predicted
that, the annual cancer cases are expected rise from14 million to 22 million
in next two decades. In addition, National Cancer Institute states that there
are approximately 1,660,290 cases reported in the United States in
2013.Technological advancement will further boost the growth of angiogenesis
inhibitor and stimulatorsmarket.For example, research in angiogenesis has
enabled identification of several angiogenesis agonist and antagonist.
However, high cost of these drugs will restrain the growth of this market.
To Get
Download Full Report with TOC:
Geographically, North America represents the largest market,
followed by Europe for angiogenesis inhibitors and stimulatorsdue to large
patient base and rise in treatment seeking population in these regions. The
market of angiogenesis inhibitors and stimulators in Asia-Pacific countries
such as India and China, South East Asian countries holds a strong growth as
there is a rise in total number of newly diagnosed patient population of
cancer in this region. According to World Health Organization, 60% of the
world’s total annual cases of cancer occur in Africa, Asia and South America.
Some of the key players in the Angiogenesis Inhibitors and
Stimulators market comprises Abbott Laboratories, Adnexus Therapeutics, Inc.,
F. Hoffman-La Roche, Ltd., Genentech, Inc., Amgen, Inc., AstraZeneca Plc.,
Novartis AG, Pfizer, Inc., Chugai Pharmaceutical Co., Ltd., EntreMed, Inc. and
Eyetech, Inc.
This research report analyzes this market depending on its
market segments, major geographies, and current market trends. Geographies
analyzed under this research report include
·
North America
·
Asia Pacific
·
Europe
·
Rest of the World
This report provides comprehensive analysis of
·
Market growth
drivers
·
Factors limiting
market growth
·
Current market
trends
·
Market structure
·
Market projections
for upcoming years
·
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
To Read
Complete Report with TOC:
Reasons for Buying this Report
·
This report provides
pin-point analysis for changing competitive dynamics
·
It provides a forward
looking perspective on different factors driving or restraining market
growth
·
It provides a
technological growth map over time to understand the industry growth rate
·
It provides a
seven-year forecast assessed on the basis of how the market is predicted to
grow
·
It helps in
understanding the key product segments and their future
·
It provides pin point
analysis of changing competition dynamics and keeps you ahead of competitors
·
It helps in making
informed business decisions by having complete insights of market and by
making in-depth analysis of market segments
·
It provides
distinctive graphics and exemplified SWOT analysis of major market segments
|
Office:
United States
|
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
Subscribe to:
Post Comments (Atom)
Powered by Blogger.
0 comments:
Post a Comment